# Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)

> **NCT00504764** · PHASE4 · COMPLETED · sponsor: **PETHEMA Foundation** · enrollment: 60 (estimated)

## Conditions studied

- Acute Promyelocytic Leukemia

## Interventions

- **DRUG:** Arsenic Trioxide
- **PROCEDURE:** Autologous Transplantation
- **PROCEDURE:** Allogenic Transplantation
- **DRUG:** ATRA

## Key facts

- **NCT ID:** NCT00504764
- **Lead sponsor:** PETHEMA Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504764, "Treatment of Relapsed Promyelocytic Leukemia With Arsenic Trioxide (ATO)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00504764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*